Bone Marrow Grafting for Leukemia and Lymphoma

This study is currently recruiting participants.
Verified February 2014 by Stanford University
Sponsor:
Collaborators:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00186147
First received: September 13, 2005
Last updated: February 12, 2014
Last verified: February 2014

September 13, 2005
February 12, 2014
March 1988
December 2018   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00186147 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bone Marrow Grafting for Leukemia and Lymphoma
Bone Marrow Grafting for Leukemia and Lymphoma

Bone Marrow Grafting for Leukemia and Lymphoma

The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Tissue samples will be obtained from subjects undergoing transplantation or donors providing the graft.

Non-Probability Sample

All hematopoietic cell transplant recipients and donors who agree to participate

  • Leukemia
  • Lymphoma
  • Hematologic Diseases
Procedure: collection and storage of tissue samples for research
Tissue samples include blood draws for the donor and recipient. A bone marrow sample may be obtained from the recipient. If the recipient undergoes a tissue biopsy for clinical reasons, a small fraction may be removed for research purposes. A small fraction of the donor graft may be removed at the time of collection for research.
Graft recipients and donors
Intervention: Procedure: collection and storage of tissue samples for research
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
9999
December 2019
December 2018   (final data collection date for primary outcome measure)

Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate

Exclusion Criteria:- Subject does not agree to participate

Both
up to 70 Years
No
Contact: Physician Referrals (650) 723-0822
United States
 
NCT00186147
BMT19, 13358, BMT19
Not Provided
Stanford University
Stanford University
  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)
Principal Investigator: David Miklos Stanford University
Principal Investigator: Robert S Negrin Stanford University
Stanford University
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP